NFA
TEVA icon

Nationwide Fund Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Nationwide Fund Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-580,391
Closed -$10.2M – 1873
2017
Q3 		$10.2M Sell
580,391
-489,719
-46% -$11M 0.04% 630
2017
Q2 		$35.5M Buy
1,070,110
+67,675
+7% +$2.09M 0.14% 134
2017
Q1 		$32.2M Sell
1,002,435
-1,256
-0.1% -$42.9K 0.13% 165
2016
Q4 		$36.4M Buy
1,003,691
+37,266
+4% +$1.49M 0.15% 125
2016
Q3 		$44.5M Sell
966,425
-15,931
-2% -$831K 0.19% 90
2016
Q2 		$49.3M Buy
982,356
+117,506
+14% +$6.26M 0.21% 78
2016
Q1 		$46.5M Buy
864,850
+200,938
+30% +$11.8M 0.2% 87
2015
Q4 		$43.6M Buy
663,912
+91,200
+16% +$5.64M 0.19% 94
2015
Q3 		$32.3M Buy
572,712
+7,174
+1% +$465K 0.15% 140
2015
Q2 		$33.4M Buy
565,538
+12,224
+2% +$754K 0.14% 154
2015
Q1 		$34.5M Buy
553,314
+14,188
+3% +$825K 0.14% 152
2014
Q4 		$31M Buy
539,126
+24,666
+5% +$1.37M 0.13% 169
2014
Q3 		$27.7M Buy
514,460
+60,574
+13% +$3.21M 0.12% 194
2014
Q2 		$23.8M Buy
453,886
+109,247
+32% +$5.58M 0.1% 249
2014
Q1 		$18.2M Sell
344,639
-7,780
-2% -$360K 0.08% 297
2013
Q4 		$14.1M Sell
352,419
-48,355
-12% -$1.9M 0.06% 409
2013
Q3 		$15.1M Buy
400,774
+35,396
+10% +$1.38M 0.07% 357
2013
Q2 		$14.3M Buy
+365,378
New +$14.2M 0.08% 310

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Nationwide Fund Advisors's TEVA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 580,391 shares — an estimated $10.2M sold.

Nationwide Fund Advisors first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $49.3M in Q2 2016. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 580,391 Teva Pharmaceuticals shares in Q4 2017, an estimated $10.2M.
  • Nationwide Fund Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Teva Pharmaceuticals position peaked at $49.3M in Q2 2016.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.